- BMI
- Body mass index: weight in kilograms divided by height in meters squared. FDA labels for weight-management GLP-1s use BMI thresholds of 30, or 27 with a weight-related condition.
- Boxed warning
- The FDA's strongest label warning. Wegovy, Ozempic and Zepbound carry one about thyroid C-cell tumors seen in rodent studies.
- Compounded drug
- A medication mixed by a pharmacy rather than made by the brand manufacturer. Compounded GLP-1s are not FDA-approved and are not equivalent to brand-name medicines.
- 503A pharmacy
- A state-licensed compounding pharmacy that prepares medications for individual patients with a prescription.
- 503B outsourcing facility
- A larger compounding facility registered with the FDA. In 2025 the FDA ended enforcement discretion for 503B compounding of semaglutide and tirzepatide.
- GIP
- Glucose-dependent insulinotropic polypeptide, a gut hormone. Tirzepatide acts on both GIP and GLP-1 receptors.
- GLP-1
- Glucagon-like peptide-1, a gut hormone that affects appetite, stomach emptying and blood sugar. GLP-1 receptor agonists mimic it.
- Manufacturer-direct pharmacy
- A self-pay pharmacy run by or for the drug maker, such as LillyDirect or NovoCare Pharmacy.
- MASH
- Metabolic dysfunction-associated steatohepatitis, a form of fatty liver disease. Wegovy has accelerated approval for certain adults with noncirrhotic MASH.
- Off-label use
- Prescribing an approved drug for a use not listed on its label, such as Ozempic for weight loss alone.
- Orforglipron
- The active ingredient in Foundayo, a small-molecule GLP-1 drug taken as a daily pill.
- An insurer's requirement to approve a medication before it will pay for it.
- Semaglutide
- A GLP-1 receptor agonist; the active ingredient in Wegovy, Ozempic and the Wegovy pill.
- Telehealth
- Healthcare delivered remotely, by questionnaire, messaging or video, by a licensed clinician.
- Tirzepatide
- A GIP and GLP-1 receptor agonist; the active ingredient in Zepbound and Mounjaro.
- Titration
- Increasing a medication's dose gradually, usually every few weeks, to reduce side effects.
See also: GLP-1 medications · All guides
GLP1Rated is for general information only and is not medical advice. GLP-1 medications are prescription drugs with real risks and side effects. Talk to a licensed clinician before starting, stopping or changing any medication or supplement.